Astera Labs Inc
NASDAQ:ALAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astera Labs Inc
NASDAQ:ALAB
|
US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
Abacus Global Management Inc
NYSE:ABX
|
US |
|
Deutsche Lufthansa AG
LSE:0H4A
|
DE |
|
Berry Global Group Inc
NYSE:BERY
|
US |
|
G
|
Geely Automobile Holdings Ltd
DUS:GRU
|
HK |
|
N
|
Nirlon Ltd
BSE:500307
|
IN |
Wall St Price Targets
ALAB Price Targets Summary
Astera Labs Inc
According to Wall Street analysts, the average 1-year price target for ALAB is 246.06 USD with a low forecast of 154.86 USD and a high forecast of 311.85 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALAB's stock price target?
Price Target
246.06
USD
According to Wall Street analysts, the average 1-year price target for ALAB is 246.06 USD with a low forecast of 154.86 USD and a high forecast of 311.85 USD.
What is the Revenue forecast for Astera Labs Inc?
Projected CAGR
25%
Over the last 2 years, the compound annual growth rate for Revenue has been 171%. The projected CAGR for the next 5 years is 25%.
What is the Operating Income forecast for Astera Labs Inc?
Projected CAGR
51%
The compound annual growth rate for Operating Income over the next 4 years is 51%.
What is the Net Income forecast for Astera Labs Inc?
Projected CAGR
37%
The compound annual growth rate for Net Income over the next 4 years is 37%.
